Genetic Regulation of Nephron Progenitor Cells in the Mammalian Kidney
哺乳动物肾脏中肾单位祖细胞的遗传调控
基本信息
- 批准号:8506855
- 负责人:
- 金额:$ 11.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-01 至 2013-08-15
- 项目状态:已结题
- 来源:
- 关键词:Cell MaintenanceCellsChoristomaChronic Kidney FailureColobomaComplementDataDefectDevelopmentDialysis procedureDisease modelDysplasiaEnd stage renal failureEndowmentEssential GenesFamilyFutureGene Expression ProfileGenesGeneticGoalsHypertensionIn VitroIntegrinsKidneyKidney DiseasesKidney TransplantationKnowledgeLeadMaintenanceMalnutritionMapsMediator of activation proteinMesenchymeMicroarray AnalysisMolecularMusMutationNephronsOptic NervePatientsPhenotypePopulationPregnancyPremature BirthProtocols documentationRegenerative MedicineRegulationRenal Replacement TherapyRepressionResourcesSeriesSpecific qualifier valueStagingStem cellsSyndromeTestingTherapeuticTimeTissuesTo specifyToxicity Testsdevelopmental diseasegain of functionhealth economicsin vivointerstitialinterstitial cellmutantnephrogenesisnovel therapeutic interventionprematureprogenitorpublic health relevanceregenerativeresearch studyself-renewal
项目摘要
DESCRIPTION (provided by applicant): Reduced endowment of the nephrons, the basic functional units of the kidney, is associated with future development of hypertension and even chronic kidney disease (CKD), ultimately leading to end stage renal disease (ESRD), a significant, growing economic health burden in the US. The PI has previously identified that the cap mesenchyme is a multipotent self-renewing nephron progenitor population during mammalian kidney development. It is critical to understand how cap mesenchyme cells are regulated during kidney development in order to develop therapeutic approaches to increase nephron endowment in situations like prematurity or malnutrition. Renal-coloboma syndrome (RCS) is a congenital developmental disorder characterized by renal hypodysplasia with reduced nephron numbers caused by PAX2 mutations. Although Pax2 has been widely recognized as an important factor for kidney development over the past two decades, Pax2 function in the developing kidney has not been investigated in vivo. Our central hypothesis supported by extensive preliminary data is that Pax2 function maintains the nephron lineage by repressing trans-differentiation into interstitial cell fates in the cap mesenchyme. In the Aim 1, we will determine cellular mechanisms for the trans-differentiation by molecular characterization of intermediate and terminally trans-differentiated cell states. We will also test whether Pax2 is sufficient to specify cap mesenchyme. In the Aim 2, we will distinguish Pax2 functions in the cap mesenchyme and differentiating nephron cells by comparing stage-specific Pax2 mutants before and after the onset of nephron differentiation. In the Aim 3, we will test our hypothesis that integrin ¿8 activity for maintenance of the nephron lineage, acting downstream of Pax2 in cap mesenchyme cells. Results from our proposed studies will initiate to uncover the genetic networks in nephron progenitor cells regulating the lineage boundary to maintain the nephron compartment during formation of the functional kidney with the full complement of nephrons.
描述(由申请人提供):肾脏的基本功能单位肾单位的捐赠减少,与高血压甚至慢性肾脏疾病(CKD)的未来发展相关,最终导致终末期肾脏疾病(ESRD),这在美国是一个重大的、日益增长的经济健康负担。PI此前已证实,在哺乳动物肾脏发育过程中,帽间充质是一种多能自我更新的肾单位祖细胞。了解在肾脏发育过程中帽间充质细胞是如何调节的是至关重要的,以便开发治疗方法,在早产或营养不良的情况下增加肾单位的捐赠。肾错构瘤综合征(RCS)是一种以PAX2基因突变引起的肾发育不良、肾单位数目减少为特征的先天性发育障碍。虽然Pax2在过去二十年中被广泛认为是肾脏发育的重要因素,但Pax2在肾脏发育中的作用还没有在体内进行研究。我们的中心假设得到了大量初步数据的支持,即Pax2功能是通过抑制帽间充质中向间质细胞命运的转分化来维持肾单位的血统。在目标1中,我们将通过对中间和末端跨分化细胞状态的分子表征来确定转分化的细胞机制。我们还将测试Pax2是否足以指定帽间充质。在目标2中,我们将通过比较Pax2在肾单位分化开始前后的阶段特异性突变来区分Pax2在帽间充质细胞和分化中的肾单位细胞中的功能。在目标3中,我们将测试我们的假设,整合素?8活性维持肾单位谱系,作用于帽间充质细胞中Pax2的下游。我们的研究结果将开始揭示肾单位祖细胞中调节谱系边界的遗传网络,以在具有完整肾单位的功能性肾脏形成过程中维持肾单位间隔。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Akio Kobayashi其他文献
Akio Kobayashi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Akio Kobayashi', 18)}}的其他基金
Genetic Regulation of Nephron Progenitor Cells in the Mammalian Kidney
哺乳动物肾脏中肾单位祖细胞的遗传调控
- 批准号:
8885811 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
Genetic Regulation of Nephron Progenitor Cells in the Mammalian Kidney
哺乳动物肾脏中肾单位祖细胞的遗传调控
- 批准号:
8643224 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
Genetic Regulation of Nephron Progenitor Cells in the Mammalian Kidney
哺乳动物肾脏中肾单位祖细胞的遗传调控
- 批准号:
8847550 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
Genetic Regulation of Nephron Progenitor Cells in the Mammalian Kidney
哺乳动物肾脏中肾单位祖细胞的遗传调控
- 批准号:
9258421 - 财政年份:2013
- 资助金额:
$ 11.65万 - 项目类别:
相似国自然基金
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
- 批准号:
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
- 批准号:82070825
- 批准年份:2020
- 资助金额:53 万元
- 项目类别:面上项目
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
- 批准号:81903002
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
- 批准号:81402419
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
- 批准号:81271563
- 批准年份:2012
- 资助金额:60.0 万元
- 项目类别:面上项目
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
- 批准号:31272541
- 批准年份:2012
- 资助金额:82.0 万元
- 项目类别:面上项目
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
- 批准号:31271248
- 批准年份:2012
- 资助金额:80.0 万元
- 项目类别:面上项目
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
- 批准号:81160050
- 批准年份:2011
- 资助金额:49.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Investigating bioengineering approaches to produce immuno-modulatory mesenchymal stromal cells and their extracellular vesicle
研究生产免疫调节间充质基质细胞及其细胞外囊泡的生物工程方法
- 批准号:
2608627 - 财政年份:2025
- 资助金额:
$ 11.65万 - 项目类别:
Studentship
Next Generation Fluorescent Tools for Measuring Autophagy Dynamics in Cells
用于测量细胞自噬动态的下一代荧光工具
- 批准号:
DP240100465 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Discovery Projects
Dissecting the heterogeniety of human tissue-resident memory T cells
剖析人体组织驻留记忆 T 细胞的异质性
- 批准号:
DE240101101 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Discovery Early Career Researcher Award
Recyclable, smart and highly efficient wire-shaped solar cells waved portable/wearable electronics
可回收、智能、高效的线形太阳能电池挥舞着便携式/可穿戴电子产品
- 批准号:
24K15389 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interplay of the extracellular matrix and immune cells in lung pathology: key role for chitinase-like proteins
肺病理学中细胞外基质和免疫细胞的相互作用:几丁质酶样蛋白的关键作用
- 批准号:
MR/Y003683/1 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Research Grant
MARVEL-ous Extracellular vesicles carry RXLR effectors into host plant cells
MARVEL-ous 细胞外囊泡携带 RXLR 效应子进入宿主植物细胞
- 批准号:
BB/Y002067/1 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Research Grant
SBIR Phase I: Industrial-Scale Technology for Drug Development in Mature Human Fat Cells
SBIR 第一阶段:成熟人类脂肪细胞药物开发的工业规模技术
- 批准号:
2322443 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Standard Grant
CAREER: Understanding how hierarchical organization of growth plate stem cells controls skeletal growth
职业:了解生长板干细胞的分层组织如何控制骨骼生长
- 批准号:
2339761 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Continuing Grant
根での内外的傷害の初動対処となる新規の傷害防衛戦略"Cellsロック"
“细胞锁”是一种新的损伤防御策略,从根源上对内伤和外伤进行初步反应。
- 批准号:
24KJ2131 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Roles of immune cells derived from clonal hematopoiesis in B-cell lymphomas
克隆造血来源的免疫细胞在 B 细胞淋巴瘤中的作用
- 批准号:
24K19213 - 财政年份:2024
- 资助金额:
$ 11.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists